A Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Comparison of the Effect of 6-Week Treatment Periods of Tiotropium Inhalation Capsules (18 µg) and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD).
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Tiotropium bromide (Primary) ; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Registrational
- Sponsors Boehringer Ingelheim
Most Recent Events
- 28 Jun 2014 New trial record